ExLibris header image
SFX Logo
Title: Comparative Effectiveness of Acupuncture and Antiarrhythmic Drugs for the Prevention of Cardiac Arrhythmias: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Source:

Frontiers in Physiology [1664-042X] Li, Yanda yr:2017


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Dungan, Kathleen M. "Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial." Lancet (London, England) 384.9951 (2014): 1349-57. Link to SFX for this item
2. Sculthorpe, N. "High Intensity Interval Training (HIIT) Improves Cardiorespiratory Fitness (CRF) in Healthy, Overweight and Obese Adolescents: A Systematic Review and Meta-Analysis of Controlled Studies." International journal of environmental research and public health. 17.8: 2955-. Link to SFX for this item
3. Drucker, L. "Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study." Lancet, The 372.9645 (2008): 1240-50. Link to SFX for this item
4. "Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study." The Lancet oncology 381.9861: 117-124. Link to SFX for this item
5. Thompson, Jennifer M. "Dulaglutide: The Newest GLP-1 Receptor Agonist for the Management of Type 2 Diabetes." The Annals of pharmacotherapy 49.3 (2015): 351-359. Link to SFX for this item
6. Wysham, C. "Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)." Diabetes care 37.8 (2014): 2159-2760. Link to SFX for this item
7. Nauck, M. "Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)." Diabetes care 37.8 (2014): 2149-2158. Link to SFX for this item
8. Rognmo, O. "High Intensity Interval Training For Maximizing Health Outcomes." Progress in cardiovascular diseases 60.1 (2017): 67-77. Link to SFX for this item
9. Blüher, S. "Cardiometabolic risk markers, adipocyte fatty acid binding protein (aFABP) and the impact of high-intensity interval training (HIIT) in obese adolescents." Metabolism, clinical and experimental 68 (2017): 77-87. Link to SFX for this item
10. Gibala, Martin J. "Physiological adaptations to low-volume, high-intensity interval training in health and disease." Journal of physiology 590.Pt 5 (2012): 1077-84. Link to Full Text for this item Link to SFX for this item
11. Baquet, G. "High-Intensity Aerobic Training During a 10 Week One-Hour Physical Education Cycle: Effects on Physical Fitness of Adolescents Aged 11 to 16." International journal of sports medicine 22.4 (2001): 295-300. Link to SFX for this item
12. Shaw, Christopher S. "The Effect of Exercise and Nutrition on Intramuscular Fat Metabolism and Insulin Sensitivity." Annual Review of Nutrition 30.1 (2010): 13-34. Link to Full Text for this item Link to SFX for this item
13. Rosenstock, J. "Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)." The Lancet 374.9683 (2009): 39-47. Link to SFX for this item
14. Barrett, Eugene J. "The endothelial cell: An "early responder" in the development of insulin resistance." Reviews in endocrine and metabolic disorders 14.1 (2013): 21-27. Link to SFX for this item
15. Blevins, T. "DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes." The Journal of clinical endocrinology and metabolism 96.5 (2011): 1301-1310. Link to SFX for this item
16. Short, Holly R. "The potential for high-intensity interval training to reduce cardiometabolic disease risk." Sports medicine 42.6 (2012): 489-509. Link to SFX for this item
17. Little, Jonathan P. "A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms." The Journal of physiology 588.6 (2010): 1011-1022. Link to Full Text for this item Link to SFX for this item
18. Pechtner, V. "Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)." Diabetes care 37.8 (2014): 2168-76. Link to SFX for this item
19. Scheen, Andre J J. "Exenatide once weekly in type 2 diabetes." Lancet, The 372.9645 (2008): 1197-8. Link to SFX for this item
20. Gibala, M. "Metabolic adaptations to short-term high-intensity interval training: A little pain for a lot of gain?" Exercise and sport sciences reviews 36.2 (2008): 58-63. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced